pargyline has been researched along with bupropion in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Snyder, AM; Stricker, EM; Zigmond, MJ | 1 |
| Joshi, MA; Manekar, MS; Muley, MP | 1 |
| Sulser, F | 1 |
| Bhyrapuneni, G; Manoharan, A; Mohammed, AR; Nirogi, R; Palacharla, RC; Ponnamaneni, RK | 1 |
1 review(s) available for pargyline and bupropion
| Article | Year |
|---|---|
Mode of action of antidepressant drugs.
Topics: Adenylyl Cyclases; Antidepressive Agents; Brain; Brain Chemistry; Brain Stem; Bupropion; Chlorpromazine; Isoproterenol; Norepinephrine; Pargyline; Propiophenones; Receptors, Adrenergic; Receptors, Serotonin; Serotonin; Trazodone | 1983 |
4 other study(ies) available for pargyline and bupropion
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Stress-induced neurological impairments in an animal model of parkinsonism.
Topics: Animals; Bupropion; Corpus Striatum; Deoxyglucose; Desipramine; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Injections, Intraventricular; Male; Neural Pathways; Norepinephrine; Oxidopamine; Pargyline; Parkinson Disease, Secondary; Propiophenones; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stress, Physiological | 1985 |
Effect of bupropion on dopamine and 5-hydroxytryptamine-mediated behaviour in mice.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Clomipramine; Dopamine; Drug Interactions; Humans; Male; Methamphetamine; Mice; Motor Activity; Pargyline; Propiophenones; Serotonin; Stereotyped Behavior | 1984 |
Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
Topics: Bupropion; Clorgyline; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2B6 Inhibitors; Drug Interactions; Glutathione; Humans; Hydroxylation; Inhibitory Concentration 50; Kinesics; Microsomes, Liver; Monoamine Oxidase Inhibitors; Pargyline; Phenelzine; Selegiline | 2015 |